Introduction {#Sec1}
============

Triterpenes, a most abundant and major class of natural products with around thirty thousand distinct structures recognized to date (Muffler et al. [@CR14]). Pentacyclic triterpenes from a biological perception have attained much attention including their derivatives. These have been marked as dietary supplements and therapeutic agents across the globe (Sheng and Sun [@CR22]). Pentacyclic triterpenes are present in human diet and in numerous medicinal plants. In addition to this, these compounds are found in cereals, vegetable oils and fruits (Siddique and Saleem [@CR25]). Average consumption of triterpenes by an individual in Western world and Mediterranean countries has been estimated as 250 mg and 400 mg per day, respectively (Moreau et al. [@CR13]). These compounds possess enormous bio-activity including cardio-protective, hepato-protective, anti-tumor, antidiabetic, antiviral, antioxidant and antiinflammatory activity (Smina et al. [@CR26]; Cichewicz and Kouzi [@CR3]; Alqahtani et al. [@CR1]; Laszczyk [@CR7]; Prasad et al. [@CR17]; Shaik et al. [@CR21]; Pádua et al. [@CR15]). Pentacyclic triterpenes have been used as anti-ulcer drugs, cancer chemotherapy and treatment and prevention of different metabolic diseases. Neuroblastoma is a harmful malignancy associated to nervous system in children (Shimada et al. [@CR24]). It occurs during the development of sympathetic nervous system and is a frequent solid extracranial tumor which symbolizes the neoplastic extension of neural crest cells (Peuchmaur et al. [@CR16]). Origination of the disease primarily happens anywhere alongside the sympathetic chain perhaps maximum chances of development are from adrenal gland. Neuroblastoma prognosis differs widely from those who bears tumors with higher frequency of spontaneous relapse and involve no intervention and those with metastatic and therapy resistant tumors (Shimada et al. [@CR23]). Tumor biology is responsible for this incongruent prognosis of neuroblastoma. Extensive research have recognized identifying characteristics of tumor that are responsible for its poor prognosis and aggressive behavior. Molecular markers and tumor histology can specifically predict the biology of tumor and these both vary according to patient's age (Campbell and Gastier-Foster [@CR2]). Current treatment strategies include immunotherapy, radiation therapy, high-dose chemotherapy with autologous cell rescue, surgical resection, chemotherapy, and isotretinoin (Smith and Foster [@CR27]). Maslinic acid belongs to pentacyclic terpenes and is found abundantly among dietary plants including hawthorn berries and olive fruit skins (Tchivounda et al. [@CR29]). This chemical entity has attained much research interest due to its high biological profile and pharmacological safety. It acts as anti-astrocytoma, anti-colonic cancer, anti-diabetogenic, anti-oxidant, anti-viral, and anti-inflammation (Randi et al. [@CR18]; Martin et al. [@CR11]). Maslinic acid was reported to inhibit TNF-α survival signaling pathway in pancreatic cells. As many studies have reported potential anticancer activity of maslinic acid, therefore, the current investigation was undertaken to check the anticancer potential of maslinic acid against the human neuroblastoma. The effects of maslinic acid to induce apoptosis, ROS generation, inhibition of cell migration and invasion, caspase activation and targeting MAPK/ERK signaling pathway were also investigated.

Materials and method {#Sec2}
====================

Cell culture and conditions {#Sec3}
---------------------------

Human neuroblastoma SHSY-5Y cell line was procured from ATCC^®^ HTB-11™ (BCRC, Taiwan). Maslinic acid (98%) was obtained from Sigma Aldrich (St. Louis, United States). DMEM (Dulbecco's modified eagle's medium, Sigma Aldrich) was used to preserve and maintain both types of cell lines. Incubation of the cells was performed in a humid atmosphere at 34 °C with 5% of carbon dioxide and 95% air. Media was placed with streptomycin (100 μg/mL), penicillin (100 U/mL), glutamine (2 mM), heat-inactivated 10% FBS (Fetal calf serum, Gibco), and HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) concentration of 20 mM (Invitrogen, Carlsbad, United States). Media was replaced after each 48 h of time interval.

Assay for proliferation assessment {#Sec4}
----------------------------------

Assessment of proliferation rate in maslinic acid treated neuroblastoma SHSY-5Y cell line was performed through execution of MTT assay. Cells were kept under given conditions within 96-well plates and precultured for 24 h followed by maslinic acid drug and control solution exposure. Variant maslinic acid doses viz 0, 5, 10, 20, 40 and 80 μM, were used for positive controls for variant time intervals viz 12 h and 48 h. Afterwards, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Tocris Bioscience) with a concentration of 0.5 mg/mL was supplied to each well plate individually followed by 2 h of incubation. Then culture media was exchanged with DMSO (Sigma) in order to dissolve formazan crystals. Further, this mixture was thoroughly centrifuged for 13 min and finally subjected to absorbance measurement. Measurements of absorbance were performed with a microplate reader (Bio-Tek, Winooski, United States).

Phase contrast microscopy {#Sec5}
-------------------------

Neuroblastoma SHSY-5Y cell line was subjected to varying maslinic acid doses viz 0, 10, 40 and 80 μM, for 24 h. Afterwards, cells were washed with PBS (Sigma) three times and subjected to staining with crystal violet (Sigma) for 5 min. Morphological alterations in neuroblastoma SHSY-5Y cell line after maslinic acid treatment were observed through inverted phase contrast microscope (OLYMPUS, CKX 41, Japan) under a magnification power of 20X.

Assay for assessment of apoptosis {#Sec6}
---------------------------------

For morphology assessment, SHSY-5Y cells were harvested at \> 90% confluence and trypsinized in 24-well plates. Each well plate contained a concentration of 4 × 10^5^ cells and maslinic acid treatment was performed for 24 h at variant doses viz 0, 10, 40 and 80 μM, under given cultural conditions. 0.1% DMSO was alone used for treatment in case of negative controls. After 24 h, fixation of the treated SHSY-5Y cells was performed with formaldehyde (4%) and then visualized using 10 μL AO/EB staining (Sigma, St. Louis) solution. Addition of staining solution was extended to 2-3mintues and finally observations were made under a fluorescence microscope (OLYMPUS, BX51TRF, Tokyo, Japan).

For annexin V/PI staining assay to quantify apoptosis similar procedure was followed except staining with annexin V/PI dual staining solution (ThermoFisher Scientific). After treatment with maslinic acid doses viz 0, 10, 40 and 80 μM, cells were subjected to 10 min of staining with AO/EB staining solution. Finally, maslinic acid treated cells were analyzed via flow cytometry using FACScan (BD Biosciences, San Diego, United States) and analyzing via Cellquest program.

Assay for caspase activity {#Sec7}
--------------------------

Neuroblastoma SHSY-5Y cells were cultured under given conditions in 96-well plates with a density of 2 × 10^5^ cells/mL. Afterwards, maslinic treatment (0, 10, 40 and 80 μM) was initiated in terms of positive controls and negative controls were only treated with 0.1% DMSO for 24 h. Caspase-Glo^®^ assay (Promega, Madison, USA) was implemented according to the manufacturer's protocol to estimate the activity of Caspase (3 and 9). Finally, luminescence was determined with a luminescence plate reader (BioTek, United States).

Assay for assessment of reactive oxygen species (ROS) {#Sec8}
-----------------------------------------------------

Intracellular ROS were quantified through Spectrofluorometry after being probed with H~2~DCFDA (Molecular Probes, Waltham, United States). Neuroblastoma SHSY-5Y cells were allowed to attach overnight at a density of 4 × 10^5^. Afterwards, attached cells were subjected to maslinic acid treatment at variant doses of 0, 10, 40 and 80 μM, including controls. The treatment lasted for 48 h followed by 10 min of incubation at 37 °C with 10 μM of H~2~DCFDA. Finally, flow cytometrically the fluorescence intensity was determined.

Assay for determination of cell migration and cell invasion {#Sec9}
-----------------------------------------------------------

24-well plates were used for migration analysis of SHSY-5Y cells after maslinic acid treatment in transwell inserts (8-mm pore size; Costar, NY, United States). Briefly, a concentration of 1 × 10^5^ cells/well along with 200 μL of SFM (serum-free medium) was loaded to upper chambers. A similar medium of 300 μL bearing control solution or variant maslinic acid doses viz 0, 10, 40 and 80 μM were loaded to lower chambers of transwell. After being incubated for 24 h, cells were then subjected to formaldehyde (3.7%) fixation for 5 min followed by staining with crystal violet 0.05% within PBS for about 15 min. The cell un-migrated on the upper filters were cleaned off and filters were washed using PBS. The underside migrated cells over filters were then analysed under light microscope and numbered. To determine the cell invasion potency of SHSY-5Y cells, transwell inserts were coated with BD Matrigel (BD Biosciences) prior to procedure. A similar experimental protocol was obeyed for invasion assay as for migration assay.

Assay for determination of protein expressions {#Sec10}
----------------------------------------------

To determine the activity of several intracellular proteins, western blotting assay was executed. In brief, SHSY-5Y cells were harvested at 75% of confluence and subjected to maslinic acid treatment at varying doses viz 0, 10, 40 and 80 μM, for 24 h. Afterwards, cell lysates were prepared by lysing of maslinic acid treated cells with lysing buffer. Protein content was determined with BCA assay and were resolved through SDS-PAGE. Resolved proteins were loaded to PVDF (immobilon polyvinylidene difluoride) membranes followed by blocking at room temperature for 1 h with BSA (4%). Afterwards, membranes were probed using 1:1000 primary antibodies against Bax, Bcl-2, Bcl-xL, MEK and ERK, at room temperature for 1 h. Membranes were then washed thrice and consequently exposed to 1:1000 peroxidase-conjugated secondary antibodies at room temperature for 1 h. Finally, bands of proteins were picturised through Kodack X-OMAT LS film (Eastman Kodak, NY, United States) by enhanced chemiluminescence.

Statistical analysis {#Sec11}
--------------------

Differential findings between controls and experiments were obtained by performing ANOVA and Student's *t* test. All the data indicated in figures were represented as mean ± SD and p \< 0.05 was considered as statistically significant. SPSS 13.0 (SPSS Inc., Chicago, IL, USA) was used analyze statistical data.

Results {#Sec12}
=======

Maslinic acid induced cytotoxicity {#Sec13}
----------------------------------

The effect of maslinic acid drug (Fig. [1](#Fig1){ref-type="fig"}) on cellular viability was estimated through MTT assay against human neuroblastoma SHSY-5Y cells. Results showed that retardation in cellular viability by maslinic acid was both concentration as well time-dependent. In SHSY-5Y positive control cells, viability was almost crushed to minimum on application of higher maslinic acid doses. The viability at controls was observed at almost 100%. On drug exposure, viability began to reduce after 12 h of exposure from 100 to 90% and then 20% on higher dose implications. The viability after 48 h of treated was reduced from 100 to 80% and then 5% on higher dose implications (Fig. [2](#Fig2){ref-type="fig"}). In negative controls viability remained adherent to normal proliferation rate.Fig. 1Chemical structure of maslinic acidFig. 2Valuation of proliferation rate in maslinic acid treated neuroblastoma SHSY-5Y cell line was achieved through accomplishment of MTT assay at indicated concentration and time intervals. The results depicting noteworthy suppression in proliferation of SHY-5Y cells in dose- and time-reliant manner as indicated. All the data indicated in this figure are represented as mean ± SD and p \< 0.05 was considered as statistically significant

Maslinic acid altered the cellular morphology {#Sec14}
---------------------------------------------

Morphological assessments were carried out through phase contrast inverted microscope. After SHSY-5Y cells were exposed to test drug for 24 h, they were analyzed and morphology of treated cells was studied against controls. Low SHSY-5Y cell confluence was recorded. Results indicated a disturbed morphology of cells treated with maslinic acid in contrast with controls which represented normal morphology. Ruptured membrane, condensed nucleus, membrane blebbing and chromatin disintegration was seen in positive controls (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Neuroblastoma SHSY-5Y cell line was subjected to changing maslinic acid doses viz 0, 10, 40 and 80 μM, for 24 h and ultimately with an inverted phase contrast microscope morphology was examined. Arrows indicate morphological changes that represent apoptosis including membrane blebbing, plasma membrane rupture and nuclear condensation. For maximum precision three individual experiments were executed

Maslinic acid induced apoptosis {#Sec15}
-------------------------------

The effect of endorsing apoptosis by maslinic acid in human neuroblastoma SHSY-5Y cells was investigated by AO/EB staining assay and its quantification was performed through Annexin V/PI dual staining. AO/EB staining assay results demonstrated that the apoptotic cell morphology of treated neuroblastoma cells in contrast to negative controls. The SHSY-5Y cells showed disintegrated DNA, nuclear fragmentation, plasma membrane rupture, membrane blebbing and condensation of nucleus (Fig. [4](#Fig4){ref-type="fig"}). These results suggested that anti-proliferation effects of maslinic acid are of its apoptosis stimulation potential. On further quantification, the percentage apoptosis enhanced from about 9% at control to about 54% on higher application of drug doses (Fig. [5](#Fig5){ref-type="fig"}). The potential of maslinic acid to endorse apoptosis in SHSY-5Y cells was further strengthened after execution of western blotting assay. Results of western blotting illustrated that the activity of anti-apoptotic protein Bcl-2 and Bcl-xL was significantly retarded on application of maslinic acid in SHSY-5Y cells. The activity of pro-apoptotic Bax protein was significantly enhanced in a dose reliant manner. The activity of caspase 3 and caspase 9 significantly enhanced as well (Fig. [6](#Fig6){ref-type="fig"}). Therefore, it was concluded from the apoptosis analysis of SHSY-5Y cells that maslinic acid is a strong apoptosis inducer and its antiproliferative effects might be due to its apoptosis inducing property.Fig. 4A concentration of 4 × 10^5^ cells was loaded to 24-well plates and maslinic acid treatment was performed for 24 h at indicated doses. Results revealed early and late apoptotic, and necrotic cellular morphology through fluorescence microscopy and represented by arrows. For maximum precision three individual experiments were executedFig. 5Flow cytometric quantification of rate of apoptosis after treatment with maslinic acid against neuroblastoma cells at indicated doses. Results indicated that percentage apoptosis increased potentially on increasing the maslinic acid concentrations as indicated. All the data indicated in this figure are represented as mean ± SD and p \< 0.05 was considered as statistically significantFig. 6Activity of the proteins allied with apoptosis (pro as well as anti) at indicated maslinic acid doses. For maximum precision three individual experiments were executed

Maslinic acid enhances reactive oxygen species (ROS) production {#Sec16}
---------------------------------------------------------------

Reactive oxygen species were recognized by performing the Spectrofluorometry after probing of treated neuroblastoma SHSY-5Y cells with H~2~DCFDA. Results indicated that the percentage of ROS production increased significantly with increasing doses of maslinic acid (Fig. [7](#Fig7){ref-type="fig"}a). The ROS species were seen with abrupt increase on application of maslinic acid from about 13% at controls to 36% at 10 μM. On higher drug doses the ROS production enhanced almost to 77% (Fig. [7](#Fig7){ref-type="fig"}b).Fig. 7**a** Spectrofluorometry analysis of neuroblastoma SHSY-5Y cells after probing with H~2~DCFDA and maslinic acid treatment. For analyzing of ROS production at indicated doses. **b** Graphical representation of outcomes from Spectrofluorometry. All the data indicated in this figure are represented as mean ± SD and p \< 0.05 was considered as statistically significant

Maslinic acid inhibits migration as well invasion {#Sec17}
-------------------------------------------------

The potential of SHSY-5Y cells to migrate and invade was testified by implementation of transwell chamber assay. After exposure to variant maslinic drug concentrations of SHSY-5Y cells cell migration was assessed. Results indicated downregulation of cell migration significantly with enhancing doses of maslinic acid (Fig. [8](#Fig8){ref-type="fig"}). The cell invasion ability was also testified with a similar procedure and results indicated that number of invaded cells was crushed to minimum on maslinic acid application (Fig. [9](#Fig9){ref-type="fig"}). Therefore, both migration and invasion of SHSY-5Y cells was reduced dose reliantly by maslinic acid.Fig. 8Images presenting the cellular migration of SHSY-5Y cells after being exposed to maslinic acid at indicated doses. For maximum precision three individual experiments were executedFig. 9Images presenting the cellular invasion of SHSY-5Y cells after being exposed to maslinic acid at indicated doses. For maximum precision three individual experiments were executed

Maslinic acid inhibited MAPK/ERK signaling pathway {#Sec18}
--------------------------------------------------

MAPK/ERK signaling pathway is an important regulatory pathway that regulates several growth and differentiation functions of a cancer cell. Several pathways have been found as therapeutic targets in cancer chemotherapy. Herein, the activity of MAPK/ERK signaling pathway was observed by analyzing the activity of its allied proteins in SHSY-5Y cells. Results indicated the activity of MEK and ERK remained almost constant allover and the activity of p-MEK and p-ERK reduced potentially with enhanced doses of maslinic acid (Fig. [10](#Fig10){ref-type="fig"}).Fig. 10Expressions of proteins associated with MAPK/ERK signaling pathway in SHSY-5Y cells after test drug treatment. For maximum precision three individual experiments were executed

Discussion {#Sec19}
==========

Neuroblastoma is a dangerous life threatening distortion effecting a huge child population globally. Poor prognosis and frequent relapse of the disease poses biggest threat to neuroblastoma patients. Current treatment strategies for neuroblastoma management do not yield fruitful outcomes and creates an emergency for novel drug candidates (Liou and Storz [@CR9]). ROS (reactive oxygen species) being extremely active metabolic by-products poses both beneficial and deleterious effects (Kumari et al. [@CR6]). ROS are involved in message transference in several cell signaling cascades that play a crucial role in maintaining cell development and differentiation. Despite of necessary importance of ROS, their overproduction leads to bimolecular irreversible damage such as proteins, carbohydrates, lipids and DNA (Liu et al. [@CR10]). This irreversible damage results in loss of cellular integrity and consequently cell pathogenesis. Production of ROS have been now identified with promotive effects on angiogenesis, metastasis, and tumorigenesis. In addition to this, accumulation and amplification of ROS in a cancer cell leads to cell death. Research has revealed that cancer cells bear's higher ROS concentration than normal cells resultant of elevated metabolic activity and malfunctioning of mitochondria (Moloney and Cotter [@CR12]). Cancer pathogenesis is controlled by the maintenance of balance among apoptosis and survival pathways. When a cell witnesses some kind of stress, p38 MAPK (mitogen-activated protein kinase) pathway stimulates apoptosis in response (Takekawa et al. [@CR28]). Chemopreventive drugs like paclitaxel and doxorubicin target p38 MAPK for induction of their anticancer effects. MAPK has been found to induce caspase dependent apoptosis (Kim et al. [@CR5]). Maslinic acid is an efficient drug candidate that has been reported with several biological functions and pharmacological functions. Maslinic acid has been reported to induce remarkable antiproliferative effects against different human cancer cell lines via stimulation of Caspase-dependent and mitochondrial mediated apoptosis (Reyes et al. [@CR19]; Reyes-Zurita et al. [@CR20]; Juan et al. [@CR4]). The anti-tumor activity of tumor necrosis factor alpha gets potentiated by maslinic acid which leads to the inhibition of NF-kappa B signaling pathway (Li et al. [@CR8]). The current research was undertaken to explore anticancer activity of maslinic acid in human neuroblastoma cell line (SHSY-5Y). Anticancer effects of maslinic acid were testified for their apoptosis induction, ROS generation, inhibition of cell migration and invasion, caspase activation and targeting MAPK/ERK signaling pathway. Maslinic acid inhibited the viability of human neuroblastoma SHSY-5Y cell line in a dose as well as time dependent manner. In addition, the antiproliferative effects were found to be selective in case of cancer cells. Investigation of underlying mechanism of antiproliferative effects of maslinic acid revealed mediation via apoptosis stimulation. The apoptotic effects were found to dependent on caspase activation. ROS production was also monitored and evidenced significant elevation in ROS production after exposure of SHSY-5Y cells to variant Maslinic acid drug doses. Maslinic acid showed tremendous anti-migration and anti-invasion potential against SHSY-5Y cells after being analyzed through transwell chambers assay. Finally, western blotting assessment indicated that the activity of proteins allied with MAPK/ERK signaling pathway was significantly blocked. From the present study it was evidenced that maslinic acid has a great potential to act as chemopreventive against neuroblastoma. The chemopreventive effects of maslinic acid were mediated via apoptosis induction, ROS generation, inhibition of cell migration and invasion, caspase activation and targeting MAPK/ERK signaling pathway.
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